BioNTech (a.k.a. Pfizer jab) starts trading on NASDAQ in October 2019. Hmmm…curious timing. A nothing burger of a company making its US debut right before a major pandemic requiring their product. Nope. Nothing to see here.
“BioNTech is the latest in a series of large biotechs going public in the US. Along with immunotherapy developers Moderna and Genmab, the three largest biotech IPOs of the past decade have all hit the market in the past 11 months.”
